SHELDON E. GREISMAN, M.D.
The therapeutic usefulness of vasopressor agents, although employed many years for correction of various shock syndromes, remains highly controversial. Some investigators disapprove of their indiscriminate use;1-3 others have advocated such therapy routinely.4, 5 The basis for the divergence of opinion may be traced to variation in interpretation of the clinical evidence. Conclusions favoring the routine employment of vasopressor therapy often fail to consider that: (1) improvement of the systemic arterial blood pressure is not synonymous with therapeutic benefit; in some instances "cures" have been ascribed to vasopressor drugs although the ultimate outcome was fatal; (2) lessening of cyanosis, though
SHELDON E. GREISMAN. THE PHYSIOLOGIC BASIS FOR VASOPRESSOR THERAPY DURING SHOCK(THE PHYSIOLOGIC BASIS FOR VASOPRESSOR THERAPY DURING SHOCK*). Ann Intern Med. 1959;50:1092–1114. doi: 10.7326/0003-4819-50-5-1092
Download citation file:
Published: Ann Intern Med. 1959;50(5):1092-1114.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use